Table 1.
Subject demographics at baseline
Characteristic | 75 mg 2CDM (n = 616) | 5 mg daily (n = 613) |
---|---|---|
Age (years), mean ± SD | 65.1 ± 7.80 | 64.2 ± 7.75 |
Lumbar spine BMD T-score, mean ± SD | −3.16 ± 0.54 | −3.17 ± 0.56 |
Total hip BMD T-score, mean ± SD | −1.91 ± 0.77 | −1.86 ± 0.78 |
uNTX/creatinine (nmol BCE/nmol), mean ± SD | 60.8 ± 39.9 | 59.0 ± 35.7 |
sBAP (μg/ml), mean ± SD | 15.13 ± 5.15 | 15.01 ± 5.37 |
BMD bone mineral density, 2CDM two consecutive days each month, sBAP serum bone-specific alkaline phosphatase, uNTX urinary N-telopeptide